138 related articles for article (PubMed ID: 2445497)
1. Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours.
Bibby MC; McDermott BJ; Double JA; Phillips RM; Loadman PM; Burgess L
Cancer Chemother Pharmacol; 1987; 20(3):203-6. PubMed ID: 2445497
[TBL] [Abstract][Full Text] [Related]
2. Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours.
Phillips RM; Bibby MC; Double JA
Cancer Chemother Pharmacol; 1988; 21(2):168-72. PubMed ID: 3127072
[TBL] [Abstract][Full Text] [Related]
3. Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatography.
van Maanen RJ; van Ooijen RD; Zwikker JW; Huitema AD; Rodenhuis S; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):103-12. PubMed ID: 9869370
[TBL] [Abstract][Full Text] [Related]
4. Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimens.
McDermott BJ; Double JA; Bibby MC; Wilman DE; Loadman PM; Turner RL
J Chromatogr; 1985 Mar; 338(2):335-45. PubMed ID: 2581984
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
Huitema AD; Mathôt RA; Tibben MM; Schellens JH; Rodenhuis S; Beijnen JH
Br J Clin Pharmacol; 2001 Jan; 51(1):61-70. PubMed ID: 11167666
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography of the anti-tumour agent triethylenethiophosphoramide and its metabolite triethylenephosphoramide with sodium sulphide, taurine and o-phthalaldehyde as pre-column fluorescent derivatization reagents.
Sano A; Matsutani S; Takitani S
J Chromatogr; 1988 Dec; 458():295-301. PubMed ID: 2466866
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
Double JA; Bibby MC; Loadman PM
Br J Cancer; 1986 Oct; 54(4):595-600. PubMed ID: 3778803
[TBL] [Abstract][Full Text] [Related]
8. Phase I/pharmacokinetic reevaluation of thioTEPA.
O'Dwyer PJ; LaCreta F; Engstrom PF; Peter R; Tartaglia L; Cole D; Litwin S; DeVito J; Poplack D; DeLap RJ
Cancer Res; 1991 Jun; 51(12):3171-6. PubMed ID: 1710167
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Br J Clin Pharmacol; 2009 Jan; 67(1):50-60. PubMed ID: 19076156
[TBL] [Abstract][Full Text] [Related]
10. The comparative disposition of the pyrolloquinone GR63178A and its 9-hydroxy metabolite GR54374X in sensitive and resistant mouse colon adenocarcinoma.
French RC; Cummings J; MacLellan A; MacPherson JS; Ritchie AA; Smyth JF
Cancer Chemother Pharmacol; 1993; 32(2):156-61. PubMed ID: 8485810
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation.
Hagen B; Dale O; Neverdal G; Azri S; Nilsen OG
Cancer Chemother Pharmacol; 1991; 28(6):441-7. PubMed ID: 1718615
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.
Hagen B
Cancer Chemother Pharmacol; 1991; 27(5):373-8. PubMed ID: 1705489
[TBL] [Abstract][Full Text] [Related]
13. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
Bibby MC; Phillips RM; Double JA
Cancer Chemother Pharmacol; 1989; 24(2):87-94. PubMed ID: 2731316
[TBL] [Abstract][Full Text] [Related]
14. Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.
Hagen B; Neverdal G; Walstad RA; Nilsen OG
Cancer Chemother Pharmacol; 1990; 25(4):257-62. PubMed ID: 1688514
[TBL] [Abstract][Full Text] [Related]
15. The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.
Bibby MC; Phillips RM; Double JA
Br J Cancer; 1991 Apr; 63(4):541-5. PubMed ID: 2021538
[TBL] [Abstract][Full Text] [Related]
16. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
[TBL] [Abstract][Full Text] [Related]
17. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
[TBL] [Abstract][Full Text] [Related]
18. Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
Cohen BE; Egorin MJ; Kohlhepp EA; Aisner J; Gutierrez PL
Cancer Treat Rep; 1986 Jul; 70(7):859-64. PubMed ID: 2424593
[TBL] [Abstract][Full Text] [Related]
19. ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.
Masters JR; McDermott BJ; Jenkins WE; Fenwick E; Shah PJ; Mundy AR; Loadman PM; Bibby MC
Cancer Chemother Pharmacol; 1990; 25(4):267-73. PubMed ID: 1688515
[TBL] [Abstract][Full Text] [Related]
20. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
Bibby MC; Double JA; Phillips RM; Loadman PM
Br J Cancer; 1987 Feb; 55(2):159-63. PubMed ID: 3814485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
